Year archive

Thiogenesis Therapeutics, Corp. — 2024 filings

All 20 regulatory filings released by Thiogenesis Therapeutics, Corp. (TTI) in 2024, sourced directly from the official regulator.

20 Filings

2024 Period

2024 filings (20)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2024-12-10	English
News release - English.pdf Share Issue/Capital Change	2024-11-28	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-11-19	English
Interim MD&A - English.pdf Management Reports	2024-11-19	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-11-19	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-11-19	English
News release - English.pdf Regulatory Filings	2024-11-04	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-08-23	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-08-23	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-08-23	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-08-23	English
News release - English.pdf Regulatory Filings	2024-08-20	English
Notice of the meeting and record date (amended) - English.pdf Regulatory Filings	2024-06-25	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2024-06-25	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-05-24	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-05-24	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-24	English
News release - English.pdf Regulatory Filings	2024-03-25	English
Report of exempt distribution (45-106F1) (amended).pdf Regulatory Filings	2024-01-30	English